Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Interest Coverage Ratio (2020 - 2024)

Whitehawk Therapeutics (WHWK) has disclosed Interest Coverage Ratio for 4 consecutive years, with 352.97 as the latest value for Q3 2024.

  • On a quarterly basis, Interest Coverage Ratio fell 14.7% to 352.97 in Q3 2024 year-over-year; TTM through Jun 2025 was 2692.87, a 780.36% decrease, with the full-year FY2024 number at 438.04, down 40.67% from a year prior.
  • Interest Coverage Ratio was 352.97 for Q3 2024 at Whitehawk Therapeutics, down from 268.69 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 17.07 in Q2 2021 to a low of 553.7 in Q3 2021.
  • A 4-year average of 272.2 and a median of 290.09 in 2023 define the central range for Interest Coverage Ratio.
  • Biggest YoY gain for Interest Coverage Ratio was 53.18% in 2022; the steepest drop was 1786.91% in 2022.
  • Whitehawk Therapeutics' Interest Coverage Ratio stood at 199.31 in 2021, then crashed by 36.19% to 271.44 in 2022, then decreased by 14.49% to 310.77 in 2023, then fell by 13.58% to 352.97 in 2024.
  • Per Business Quant, the three most recent readings for WHWK's Interest Coverage Ratio are 352.97 (Q3 2024), 268.69 (Q2 2024), and 336.41 (Q1 2024).